Angelica Leticia Alvarado, | |
2500 E Foothill Blvd, Pasadena, CA 91107-3464 | |
(626) 564-1613 | |
Not Available |
Full Name | Angelica Leticia Alvarado |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 2500 E Foothill Blvd, Pasadena, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013296987 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Secondary |
1041C0700X | Social Worker - Clinical | 72282 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Angelica Leticia Alvarado, 2500 E Foothill Blvd, Pasadena, CA 91107-3464 Ph: (626) 993-3000 | Angelica Leticia Alvarado, 2500 E Foothill Blvd, Pasadena, CA 91107-3464 Ph: (626) 564-1613 |
News Archive
"A large number of high school athletes take the winter off and just go out and start throwing as hard as they can," said Matt Holland, a physical therapist with The Methodist Center for Sports Medicine in Houston. "The problem is that their arms are not in baseball shape and they open themselves up to serious shoulder and elbow injuries."
A sophisticated microscope that offers a "real-time" 3-D analysis of tissue samples might, in the future, reduce the number of needle biopsies traditionally needed from women suspected of having breast cancer, according to recent research published at Georgetown University Medical Center's Lombardi Comprehensive Cancer Center.
OptumHealth Inc. has teamed with The Children's Hospital of Philadelphia (CHOP) to present a two-day educational conference focused on clinical advancements in fetal diagnosis and treatment, neonatal care and pediatric care. The gathering runs through today, and is part of OptumHealth's Network Spotlight Conferences program.
Restore Health, a company specializing in personalized medicine, announced today that its specialty pharmacy division is in the process of seeking accreditation from URAC, a Washington, D.C.-based healthcare accrediting organization that establishes quality standards for the healthcare industry.
A new Mayo Clinic study found that the clinical criteria for mild cognitive impairment is better at predicting who will develop Alzheimer's disease than a single memory test. This is one more piece of information to aid in the identification and early treatment of individuals most likely to develop Alzheimer's disease. This study will be presented at the Alzheimer's Association International Conference on Alzheimer's Disease on July 14 in Vienna.
› Verified 4 days ago